Press-release for stocks for abbvie inc. for ucbjy

| -5.41% | O: 0.14% H: 0.0% C: -0.0%
SNYNF | News | $92.7 600K

| -3.13% | O: 0.26% H: 1.36% C: 1.36%
AZNCF | News | $138.73 3.7K

| 9.24% | O: -0.85% H: 1.12% C: 0.43%
NVSEF | News | $95.11 490

| -6.69% | O: 0.92% H: 0.0% C: 0.0%
UCBJY | $64.93 6.2K

| 27.56% | O: 1.46% H: 0.44% C: 0.44%
ALPMY | News | $9.53 690K

| -14.3% | O: -0.27% H: 0.0% C: -1.17%
TAK | News | $13.41 0.37% 1M

| -9.36% | O: -0.2% H: 0.14% C: -0.48%
NVS | News | $97.25 2.24% 2.6M

| -7.6% | O: -0.06% H: 0.46% C: 0.29%
GSK | News | $41.165 1.42% 1.3M

| -3.22% | O: -0.69% H: 1.42% C: 1.22%
LLY | News | $744.47 1.8% 1M

| -1.95% | O: 2.37% H: 1.51% C: 0.79%
BMY | $49.225 0.17% 3.9M

| -3.48% | O: -0.65% H: 1.63% C: 1.48%
ABBV | News | $170.2 1.38% 2M

| -4.79% | O: -0.88% H: 1.46% C: 1.13%
SNY | News | $47.72 1.21% 1.1M

| -1.81% | O: 1.67% H: 0.0% C: 0.0%
AZN | News | $70.93 1.14% 3.8M

| 7.74% | O: -2.81% H: 2.08% C: 1.38%
AMGN | News | $274.12 0.81% 1.2M

| -4.07% | O: -0.35% H: 1.15% C: 0.96%
lung reach cancer cell diagnostics therapy market

Blood Cancer Drugs Market Report 2023: Reveals Striking Growth Prospects with a Surge in R&D Activities - Long-term Forecasts to 2028 and 2033
Published: 2024-02-06 (Crawled : 00:00) - prnewswire.com
ALPMF | News | $9.75 200

| -12.32% | O: -1.53% H: 0.0% C: 0.0%
AZNCF | News | $138.73 3.7K

| 3.65% | O: -0.37% H: 0.0% C: 0.0%
NVSEF | News | $95.11 490

| -7.55% | O: 0.41% H: 0.0% C: 0.0%
UCBJY | $64.93 6.2K

| 38.86% | O: 1.71% H: 1.28% C: 0.94%
ALPMY | News | $9.53 690K

| -12.49% | O: 0.28% H: 0.18% C: 0.0%
TAK | News | $13.41 0.37% 1M

| -5.65% | O: 0.07% H: 0.42% C: 0.07%
NVS | News | $97.25 2.24% 2.6M

| -8.65% | O: 0.09% H: 0.39% C: -0.36%
JNJ | News | $150.09 0.65% 4.9M

| -4.25% | O: 1.47% H: 0.0% C: 0.0%
LLY | News | $744.47 1.8% 1M

| 3.73% | O: 0.76% H: 4.31% C: 2.11%
BMY | $49.225 0.17% 3.9M

| -0.24% | O: -0.14% H: 0.35% C: -1.12%
ABBV | News | $170.2 1.38% 2M

| -1.83% | O: 1.48% H: 0.0% C: 0.0%
VRTX | $405.165 1.31% 390K

| -4.46% | O: 0.15% H: 2.4% C: 0.56%
SNY | News | $47.72 1.21% 1.1M

| -0.55% | O: 1.33% H: 0.0% C: 0.0%
JAZZ | $109.55 0.66% 180K

| -12.73% | O: -0.02% H: 0.0% C: -1.4%
AZN | News | $70.93 1.14% 3.8M

| 4.61% | O: -0.4% H: 0.19% C: -0.33%
AMGN | News | $274.12 0.81% 1.2M

| -13.97% | O: -0.18% H: 0.0% C: -6.22%
report cancer blood growth market

Key Players Such as AbbVie, Roche, and Amgen Dominate the Competitive Landscape of the Expanding Cytokine Market
Published: 2023-11-03 (Crawled : 01:00) - prnewswire.com
UCBJF | $128.725 750

| 71.51% | O: -1.4% H: 0.0% C: 0.0%
UCBJY | $64.93 6.2K

| 77.21% | O: 0.48% H: 1.02% C: 0.42%
TMO | News | $575.155 4.88% 1.4M

| 23.4% | O: 2.32% H: 0.0% C: 0.0%
ABBV | News | $170.2 1.38% 2M

| 18.87% | O: 1.88% H: 0.0% C: 0.0%
TECH | $64.115 2.09% 500K

| 13.34% | O: 2.71% H: 4.38% C: 3.18%
AMGN | News | $274.12 0.81% 1.2M

| 2.0% | O: 0.72% H: 0.76% C: 0.5%
ABCM | News | $23.99 0.0% 7.4M

| 3.63% | O: 0.0% H: 0.0% C: 0.0%
market

Leading Players Pfizer, AbbVie, and Novartis at the Forefront of Advancements in Plaque Psoriasis Treatment
Published: 2023-09-20 (Crawled : 22:00) - prnewswire.com
UCBJY | $64.93 6.2K

| 43.68% | O: -0.79% H: 0.0% C: -1.26%
NVS | News | $97.25 2.24% 2.6M

| -8.51% | O: -0.7% H: 0.06% C: -0.75%
LLY | News | $744.47 1.8% 1M

| 27.46% | O: -1.47% H: 0.0% C: 0.0%
ABBV | News | $170.2 1.38% 2M

| 9.2% | O: -0.04% H: 0.76% C: -0.16%
SNY | News | $47.72 1.21% 1.1M

| -16.49% | O: -1.16% H: 0.0% C: 0.0%
AMGN | News | $274.12 0.81% 1.2M

| 0.17% | O: 0.22% H: 0.15% C: -0.98%
psoriasis treatment novartis

Global CNS Therapeutics Strategic Business Report 2023: Burgeoning Global Aging Populace, Longer Life Expectancy to Drive CNS Demand
Published: 2023-06-30 (Crawled : 23:00) - prnewswire.com
ALKS | $24.48 1.7% 640K

| Email alert Add to watchlist
JNJ | News | $150.09 0.65% 4.9M

| Email alert Add to watchlist
NBIX | News M | $140.81 5.35% 920K

| Email alert Add to watchlist
SNYNF | News | $92.7 600K

| Email alert Add to watchlist
UCBJY | $64.93 6.2K

| Email alert Add to watchlist
UCBJF | $128.725 750

| Email alert Add to watchlist
AZNCF | News | $138.73 3.7K

| Email alert Add to watchlist
PFE | News A | $26.29 0.11% 14M

| Email alert Add to watchlist
TAK | News | $13.41 0.37% 1M

| Email alert Add to watchlist
NVSEF | News | $95.11 490

| Email alert Add to watchlist
NVS | News | $97.25 2.24% 2.6M

| Email alert Add to watchlist
BMY | $49.225 0.17% 3.9M

| Email alert Add to watchlist
AZN | News | $70.93 1.14% 3.8M

| Email alert Add to watchlist
TEVJF | News | $12.37 -24.22% 380

| Email alert Add to watchlist
LLY | News | $744.47 1.8% 1M

| Email alert Add to watchlist
SNY | News | $47.72 1.21% 1.1M

| Email alert Add to watchlist
ABBV | News | $170.2 1.38% 2M

| Email alert Add to watchlist
report business life global therapeutics

Global Acute Repetitive Seizures Market to Showcase Promising Growth says Brandessence Market Research
Published: 2023-05-15 (Crawled : 10:00) - prnewswire.com
UCBJY | $64.93 6.2K

| 40.69% | O: 1.79% H: 0.18% C: -0.06%
TAK | News | $13.41 0.37% 1M

| -18.44% | O: 0.61% H: 0.3% C: 0.24%
JNJ | News | $150.09 0.65% 4.9M

| -7.25% | O: 0.01% H: 0.14% C: -0.78%
LLY | News | $744.47 1.8% 1M

| 68.34% | O: 0.22% H: 0.14% C: -0.2%
ABBV | News | $170.2 1.38% 2M

| 14.09% | O: 0.35% H: 0.83% C: -0.73%
VRTX | $405.165 1.31% 390K

| 14.44% | O: 0.17% H: 1.07% C: 0.19%
SNY | News | $47.72 1.21% 1.1M

| -14.45% | O: 0.38% H: 0.0% C: 0.0%
GILD | $67.37 0.63% 2.4M

| -14.35% | O: -0.13% H: 0.42% C: 0.4%
research global growth market

Global Best Selling Pharmaceutical Drugs Analysis Report 2023: Revenue Forecast of the Top 50 Pharmaceutical Drugs and Assessment of their Regulatory Landscape through 2021
Published: 2023-03-10 (Crawled : 20:00) - prnewswire.com
AMGN | News | $274.12 0.81% 1.2M

| Email alert Add to watchlist
CSLLY | $89.17 54K

| Email alert Add to watchlist
MNK | $0.3402 -0.06% 540K

| Email alert Add to watchlist
SNY | News | $47.72 1.21% 1.1M

| Email alert Add to watchlist
GLAXF | News | $20.305 630

| Email alert Add to watchlist
MNKPF | $17.25

| Email alert Add to watchlist
ABBV | News | $170.2 1.38% 2M

| Email alert Add to watchlist
ENDP | News | $0.2926 -9.6%

| Email alert Add to watchlist
ALPMY | News | $9.53 690K

| Email alert Add to watchlist
VTRS | News A | $11.355 0.93% 2.3M

| Email alert Add to watchlist
NVSEF | News | $95.11 490

| Email alert Add to watchlist
UCBJY | $64.93 6.2K

| Email alert Add to watchlist
NVS | News | $97.25 2.24% 2.6M

| Email alert Add to watchlist
ALPMF | News | $9.75 200

| Email alert Add to watchlist
SNYNF | News | $92.7 600K

| Email alert Add to watchlist
BHC | $8.565 1.36% 1.2M

| Email alert Add to watchlist
UCBJF | $128.725 750

| Email alert Add to watchlist
TEVJF | News | $12.37 -24.22% 380

| Email alert Add to watchlist
ENDPQ | News | $0.0007 -50.0% 1K

| Email alert Add to watchlist
CMXHF | $176.0 50

| Email alert Add to watchlist
JNJ | News | $150.09 0.65% 4.9M

| Email alert Add to watchlist
MNKKQ | $0.02

| Email alert Add to watchlist
GSK | News | $41.165 1.42% 1.3M

| Email alert Add to watchlist
NVO | News | $128.15 2.31% 2.6M

| Email alert Add to watchlist
global report

China Anti-Rheumatic Drug Markets Report 2022-2027 Featuring Pfizer, F. Hoffmann-La Roche, UCB S.A., Eli Lilly and Company, & AbbVie Inc.
Published: 2023-01-24 (Crawled : 12:00) - prnewswire.com
UCBJY | $64.93 6.2K

| 54.56% | O: -1.31% H: 0.39% C: 0.17%
LLY | News | $744.47 1.8% 1M

| 113.71% | O: 12.34% H: 0.0% C: -9.9%
ABBV | News | $170.2 1.38% 2M

| 13.02% | O: -0.32% H: 0.53% C: -0.26%
drug abbvie report china

Global Cybersecurity Market Analysis Report 2022-2027 - Increasing Focus on Solution-centric Security Capabilities and Rising Vulnerabilities on Endpoint Devices
Published: 2023-01-24 (Crawled : 12:00) - prnewswire.com
UCBJY | $64.93 6.2K

| 54.56% | O: -1.31% H: 0.39% C: 0.17%
LLY | News | $744.47 1.8% 1M

| 113.71% | O: 12.34% H: 0.0% C: -9.9%
ABBV | News | $170.2 1.38% 2M

| 13.02% | O: -0.32% H: 0.53% C: -0.26%
SPLK | $156.9 -0.04% 18M

| 68.53% | O: -0.25% H: 1.85% C: -0.59%
MSFT | News F | $407.2 1.56% 8.5M

| 65.29% | O: -0.03% H: 0.6% C: -0.19%
CYBR | News | $240.58 2.52% 180K

| 72.15% | O: -0.14% H: 1.37% C: 0.01%
CHKP | News | $161.11 1.46% 450K

| 23.06% | O: -0.17% H: 1.12% C: -0.55%
global report cybersecurity security market

World Connected Logistics Markets Report 2022-2029: Rising Need for Efficient Warehouse Management Driving Growth with Increasing Adoption of IoT and Cloud Technologies
Published: 2023-01-24 (Crawled : 12:00) - prnewswire.com
UCBJY | $64.93 6.2K

| 54.56% | O: -1.31% H: 0.39% C: 0.17%
IBM | $183.255 0.75% 3.8M

| 28.23% | O: -0.43% H: 1.06% C: 0.17%
INFY | $17.18 -0.69% 4.6M

| -9.19% | O: -0.42% H: 0.16% C: -0.37%
HON | News M | $196.375 0.41% 1M

Producer Manufacturing

| -4.34% | O: -0.24% H: 1.82% C: 1.46%
LLY | News | $744.47 1.8% 1M

| 113.71% | O: 12.34% H: 0.0% C: -9.9%
ABBV | News | $170.2 1.38% 2M

| 13.02% | O: -0.32% H: 0.53% C: -0.26%
INTC | $34.43 0.06% 22M

Electronic Technology

| 13.68% | O: -1.09% H: 0.84% C: -0.07%
management report growth iot cloud

$121 Billion Worldwide Cytokine Industry to 2027 - Featuring AbbVie, Abcam, Amgen and Applied Biological Materials Among Others
Published: 2023-01-10 (Crawled : 12:00) - prnewswire.com
UCBJY | $64.93 6.2K

| 54.6% | O: -0.31% H: 0.5% C: 0.0%
TMO | News | $575.155 4.88% 1.4M

| 0.42% | O: 0.25% H: 4.59% C: 3.76%
ABBV | News | $170.2 1.38% 2M

| 3.85% | O: 0.35% H: 0.12% C: -1.6%
TECH | $64.115 2.09% 500K

| -25.18% | O: 1.02% H: 2.28% C: 2.05%
AMGN | News | $274.12 0.81% 1.2M

| 0.66% | O: 0.68% H: 0.98% C: 0.71%
ABCM | News | $23.99 0.0% 7.4M

| 46.37% | O: -1.28% H: 2.9% C: 2.1%

Outlook on the Pharmaceutical Drugs Global Market to 2027: Look at the Changing Structure of the Pharma and Healthcare Industry
Published: 2023-01-03 (Crawled : 13:00) - prnewswire.com
ENDPQ | News | $0.0007 -50.0% 1K

| -94.35% | O: -1.13% H: 28.57% C: 19.0%
CSLLY | $89.17 54K

| -8.58% | O: -3.93% H: 2.17% C: 1.75%
MNK | $0.3402 -0.06% 540K

| -94.75% | O: 3.1% H: 0.0% C: -2.75%
GLAXF | News | $20.305 630

| 16.1% | O: -0.2% H: 2.06% C: 2.06%
SNYNF | News | $92.7 600K

| -3.71% | O: 1.09% H: 0.54% C: 0.54%
UCBJY | $64.93 6.2K

| 65.22% | O: 1.0% H: 0.0% C: -0.26%
ALPMY | News | $9.53 690K

| -37.14% | O: 3.43% H: 0.0% C: -2.93%
VTRS | News A | $11.355 0.93% 2.3M

| 1.08% | O: 0.54% H: 2.5% C: 1.7%
NVO | News | $128.15 2.31% 2.6M

| -7.45% | O: 1.43% H: 0.84% C: -0.23%
NVS | News | $97.25 2.24% 2.6M

| 4.46% | O: 0.42% H: 1.35% C: 1.22%
JNJ | News | $150.09 0.65% 4.9M

| -15.58% | O: -0.28% H: 1.26% C: 1.15%
GSK | News | $41.165 1.42% 1.3M

| 15.51% | O: -0.57% H: 1.35% C: 1.0%
BHC | $8.565 1.36% 1.2M

| 34.55% | O: 0.48% H: 3.96% C: -0.48%
ABBV | News | $170.2 1.38% 2M

| 3.89% | O: 0.27% H: 0.6% C: 0.21%
SNY | News | $47.72 1.21% 1.1M

| -4.31% | O: 0.16% H: 0.0% C: 0.0%
AMGN | News | $274.12 0.81% 1.2M

| 3.53% | O: -0.67% H: 0.66% C: 0.3%
pharma global market

Disease-Modifying Antirheumatic Drug (DMARD) Market to Surpass US$ 27,167.8 Million by 2030 - Coherent Market Insights
Published: 2022-09-06 (Crawled : 19:00) - prnewswire.com
SNYNF | News | $92.7 600K

| 17.12% | O: -3.02% H: 0.0% C: 0.0%
UCBJY | $64.93 6.2K

| 89.02% | O: 0.73% H: 2.28% C: 1.72%
JNJ | News | $150.09 0.65% 4.9M

| -9.06% | O: -0.65% H: 0.93% C: 0.71%
BMY | $49.225 0.17% 3.9M

| -28.42% | O: 0.03% H: 1.18% C: 0.13%
ABBV | News | $170.2 1.38% 2M

| 22.02% | O: -0.03% H: 1.08% C: 0.84%
SNY | News | $47.72 1.21% 1.1M

| 16.17% | O: 0.49% H: 0.0% C: 0.0%
GILD | $67.37 0.63% 2.4M

| 5.62% | O: 0.44% H: 2.03% C: 1.76%
CPIX | $1.62 2K

| -26.7% | O: -4.52% H: 7.12% C: 5.69%
AMGN | News | $274.12 0.81% 1.2M

| 12.26% | O: 0.24% H: 1.04% C: 0.82%
drug market

Global Axial Spondyloarthritis Market Research Repoirt 2022: Biopharmaceutical Companies are Trying to Match Themselves with New Technologies in the Market to Improve the Overall System
Published: 2022-06-14 (Crawled : 11:00) - prnewswire.com
UCBJY | $64.93 6.2K

| 57.14% | O: -0.22% H: 0.0% C: -1.02%
TAK | News | $13.41 0.37% 1M

| 0.6% | O: -0.04% H: 0.0% C: 0.0%
PFE | News A | $26.29 0.11% 14M

| -46.14% | O: -2.24% H: 0.0% C: 0.0%
JNJ | News | $150.09 0.65% 4.9M

| -12.44% | O: 0.43% H: 0.0% C: 0.0%
LLY | News | $744.47 1.8% 1M

| 151.67% | O: -0.49% H: 0.98% C: 0.56%
BMY | $49.225 0.17% 3.9M

| -33.45% | O: -0.4% H: 0.33% C: -0.91%
ABBV | News | $170.2 1.38% 2M

| 19.16% | O: -1.04% H: 0.87% C: -1.31%
AMGN | News | $274.12 0.81% 1.2M

| 14.28% | O: -0.41% H: 0.73% C: -0.54%
research system companies market

Gainers vs Losers

87%

13%

Top 10 Gainers

MTTR | News M | $4.56 162.07% 21M

AGBA | $2.74 119.2% 52M

Finance

CZOO | $9.07 81.76% 22M

EDBL | News | $6.56 74.47% 1.8M

MTC | $2.21 41.67% 5.6M

OPRT | News | $3.12 38.67% 11M

Finance

PALI | $6.59 33.67% 23M

VNRX | $0.7945 32.42% 3.1M

MLEC | $1.81 29.29% 2.8M